GPNMB is overexpressed in a number of cancer types [16, 17] and was first shown to be transcriptionally regulated by MITF [18, 19], but subsequently was identified as a direct transcriptional target of TFE3 and is highly expressed in TFE3-fusion RCC [20, 21]. Here, GPNMB is linked to cancer.